State receives $200,000 in drug settlement
Updated On: Jul 16 2014 11:35:33 AM CDT
Wisconsin will receive $200,000 for its Medicaid program from the settlement of a multi-state lawsuit accusing a pharmaceutical company of improperly marketing a drug.
Wisconsin State Journal reported Wednesday that Illinois-based Astellas Pharma US Inc. will pay a total of $7.3 million in the settlement with multiple states and the federal government.
The Wisconsin Attorney General's Office said in a statement that the company promoted pediatric use of the drug Mycamine from 2005 to 2010, even though the Food and Drug Administration hadn't approved it for children.
The anti-fungal agent is approved for use in adults with certain infections. It also can be used to prevent infections in adults undergoing stem cell transplants.
Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.